Investors' Chronicle

Town Centre Securities (TOWN) is one of the UK market’s oldest names. Founded, managed and largely controlled by the Ziffs of Leeds since its listing in 1960, it is a typical John Lee stock: a cash-generative, dividend-paying, and storied family business with roots in the North.Another factor explains John’s recent decision to start building a stake in the group. At £1.15p, Town Centre’s share price trades well below half of the company’s net asset value.In this latest CEO interview, John and IC associate editor Alex Newman speak with Town Centre’s chief executive and chairman, Edward Ziff, about the business’s past and present, and the prospects for closing that enormous valuation gap.Let us know your thoughts, or if you have any questions or any suggestions for future guests, by emailing alex.newman@ft.com.Listen to more podcasts from Investors’ Chronicle by clicking here or heading to Apple, Spotify and YouTube.Timestamps:00:00 - Introduction00:30 - How developments in Iran are affecting Lord Lee's investing plans03:25 - Dr. Edward Ziff explains Town Centre Securities business07:13 - How Town Centre Securities real estate assets are spread11:44 - Recent performance of Town Centre Securities15:40 - Lord Lee's previous dealings with Town Centre Securities19:07 - How important leverage and loan-to-value ratio is to the business23:36 - Town Centre Securities' Debenture 28:49 - Moving out of REIT status34:01 - Succession plans and family-run businesses39:29 - Lord Lee discusses his portfolioInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.

It’s another day chock-full of company results, albeit market attention is understandably still focused elsewhere given the events in the Middle East over the past week. So today, we too will be discussing the implications of the US/Israel war with Iran. Mike Fahy is here to talk about energy, defence, and the implications for the UK and European economies. After that, we turn to our big read of the week. The healthcare sector has typically been seen as a port in a storm during troubled times, and after a tough few years there had been signs of a revival even prior to the latest nerves. Julian Hofmann will dive into the detail and ask whether this momentum can continue.Finally, next week marks the publication of our annual Isa special. With big reforms on the way for these popular savings accounts, personal finance editor Holly McKechnie joins us to discuss what’s happening, as well as outlining some practical steps listeners can take to meet their savings goals.Timestamps:00:00: Intro01:06: War in Iran13:32: Healthcare resurgence26:05: Isa changesFind out more:‘Operation Epic Fury’ creates more noise for defence sharesRead all the latest stocks & shares news and analysis hereHow to invest in the healthcare revivalInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.

Company results season is under way. We have a mass of companies reporting over the next couple of weeks, and we will dig in to one of the highest profile businesses on the FTSE 100 later in the show.To start, though, we are looking at a lesser-known stock, albeit one whose shares have been surging higher for several years now: Lion Finance (BGEO), itself not far from FTSE 100 promotion, and which reported another set of well-received figures of its own earlier this week. Alex Newman asks whether the run can last.Then, our big read this week is all about the existential question of the day: is AI working? With investors hopes and indeed fears now seemingly pinned on the technology, Valeria Martinez is here to discuss how companies outside the tech sector are applying AI in practice, and how effectively or otherwise they are being.In our third segment we’ll look at a noted AI loser of recent months, albeit one that nonetheless put out a fairly superlative set of results this morning: London Stock Exchange (LSEG). Hugh Moorhead will take us through the risks and opportunities facing the business, and consider whether the sell-off has been overdone.Read more:Can investors ignore the FTSE 100’s next big bank?Lion Finance’s profits exceed expectationsNext-generation AI stocks worth buying nowTimestamps:00:00 Intro01:12 Lion Finance17:10 AI winners33:56 London Stock Exchange GroupInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.

Christie Group has a lot going for it. Growing in several countries and an employer to around 650 people, the brokerage business is a well-respected name in multiple niche sectors. Last year sales exceeded £70mn, and management reckons operating profits of £10mn are possible. The kicker, following the disposal of several subsidiaries, is that its balance sheet is full of cash.Lord Lee of Trafford clearly agrees. In more than 80 transactions since 2002, he has amassed a 6 per cent holding across both his personal investment account and the charitable trusts he oversees.So why is the business valued at just £35mn? We put this question and many more to chief executive Dan Prickett, who has been at the company for 17 years - including the last two and a half in the top role.Listen to more podcasts from Investors’ Chronicle on Apple, Spotify and YouTubeTimestamps00:00 Intro00:30 Recap of last episode01:44 Introducing Dan Prickett02:21 What is Christie's05:10 John's history with the business09:37 Institutional shareholders12:10 Dan's stake in the business15:08 Trading statement23:40 Why is the stock price low?30:18 Expansion in Europe35:49 Setting targets37:08 John's portfolio round up39:25 PZ CussonsInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.

This week, after a software sell-off that has rattled some of the UK’s most popular ‘quality’ stocks, we look at the fallout for the likes of Relx, Sage, Experian and others. Valeria Martinez is here to discuss whether the launch of Anthropic’s new AI tools represents an existential threat to these businesses.After that, we turn to the hopefully calmer world of corporate bonds and the reforms that have the potential to open up the market more widely to DIY investors. Erin Withey talks through the changes, their likely impact on the market, and what corporate debt in general can offer investors.To wrap up, we look at one of the many companies to have updated the market this week, in the form of pharma giant GSK. After many years out of favour, the business has started to win investors over of late. Julian Hofmann will look at how it’s done it, whether its progress can continue, and what a new chief executive might bring to the business.Read more:AI-hit software stocks bounce backGSK starts to show real profit improvementTimestamps00:00 Intro01:00: Software sell-off12:37 Corporate bonds21:43 GSKInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.

It’s been a dramatic week in a year already full of drama, with Donald Trump’s sabre rattling over Greenland, and subsequent threat to impose further tariffs, causing alarm before being walked back on the basis of an apparent compromise.But with that saga now seemingly in the rear-view mirror – for how long, we don’t know – we kick things off today with space exploration, which does have specific application to the current geopolitical debates as we shall discuss shortly. Mike Fahy is on hand to examine how the soaring space sector is faring ahead of a possible SpaceX IPO later this year.Then it’s on to the latest part of the tech sector to attract widespread investor interest as a result of the AI craze: memory chip stocks in the US and further afield have been booming as people cotton on to the vital role they play in data centres. Arthur Sants, recently returned from a trip to the factories of South Korea, will discuss shares, shortages and smartphone prices, among other things.And to finish up we will be back on home turf as Julian Hofmann joins us to discuss the bid interest in Lloyd’s insurer Beazley from Zurich, and the prospects for more consolidation across the sector in general.Timestamps 00:00 Intro1:29 Space Industry13:11 Memory chips21:43 Beazley takeover offerInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.

It may be dry January for some, but this week we are settling down with the pub companies amid a raft of news for the sector in recent days. Mark Robinson is here to discuss the bumper Christmas periods that many in the sector enjoyed, the imminent U-turn on business rate hikes likely to be announced by the government in the days ahead, the US activist putting the pressure on Marston’s (MARS) and more.After that we turn our attention to one government reform that’s not being reversed – the Renters’ Rights Act is due to come into force this year, and that puts pressure on landlords to comply. Holly McKechnie will explain what that means for the rental market, and also talk us through the other changes coming in that could have an even bigger impact on buy-to-let properties.Lastly, we look at gene sequencing device maker Oxford Nanopore Technologies (ONT), one of the 2021 UK IPOs that have done especially badly, but which has shown some signs of life in recent months. Julian Hofmann will examine the company’s full-year trading update for clues to its future prospects.Timestamps00:00 Intro01:06 Pubs winter rally14:20 Renters' Rights Act26:26 Oxford NanoporeRead the articles highlighted in the show:Mitchells & Butlers: Pricier pints power profit growthDoes it still pay to be a landlord?Oxford Nanopore returns to growthInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.